In the ovarian cancer cases, there were 23 cases of reduced copy number and reduced expression of MLH1, 3 cases with a LOF mutation in an MMR gene and 2 cases with a predicted deleterious missense mutation in an MMR gene; all of these cases had alterations affecting other GIS genes. This evidence concerns the gene MLH1 and ovarian cancer.